More importantly, we have shown that higher GLI1/ ABCG2 expression is associated with poor survival of gastric cancer patients who underwent CDDP-based chemotherapy (Figure 8 and Supplementary Figure 9). The gene discussed is GLI1; the disease is gastric cancer.